Skip to main content

iQure Pharma

Wilmington, United States

iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.

$1.5M raised
Nov 2025
Venture - Series Unknown

Top Investors

National Institutes of HealthKeiretsu ForumKeiretsu Forum NorthwestKeiretsu Forum Mid AtlanticOKG Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about iQure Pharma

How much funding has iQure Pharma raised?
iQure Pharma has raised $1.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Who are iQure Pharma's investors?
iQure Pharma's investors include National Institutes of Health, Keiretsu Forum, Keiretsu Forum Northwest, Keiretsu Forum Mid Atlantic, OKG Capital.
Where is iQure Pharma headquartered?
iQure Pharma is headquartered in Wilmington, United States.
What does iQure Pharma do?
iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
What stage is iQure Pharma at?
iQure Pharma is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"iQure Pharma — Funding & Investors." VCBacked, November 3, 2025, https://www.vcbacked.co/company/iqure-pharma. Accessed June 4, 2026.
APA
VCBacked. (2025). iQure Pharma — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/iqure-pharma
Wikipedia (cite web)
{{cite web |title=iQure Pharma — Funding & Investors |url=https://www.vcbacked.co/company/iqure-pharma |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .